Digitalisation and adoption of AI-powered instruments have already turn out to be defining developments throughout the pharmaceutical sector. They’re shaping how the complete trade works, from early analysis to large-scale manufacturing and logistics. Corporations are more and more turning to sensible instruments and data-driven options to spice up effectivity, enhance transparency and construct extra resilient programs for the longer term.
At the Pharmaceutical Automation and Digitalisation Congress AUTOMA+ 2025 (24-25 November, Vösendorf, Austria), these subjects are going to be within the highlight. The Сongress is bringing collectively 290+ professionals and decision-makers from throughout the pharmaceutical worth chain. The contributors are going to share experience and opinions on how digital applied sciences are remodeling the way in which medicines are found, developed and delivered. This text explores a few of the initiatives and important subjects to be mentioned through the Congress – with a deal with lab automation, provide chain optimisation and new approaches in compliance.
Digital-driven R&D
CellVoyant, an AI-first biotech firm on a mission to remedy continual illnesses, is utilizing reside cell imaging and machine studying to foretell and optimise stem cell differentiation. The workforce fuses biology and engineering to unlock the way forward for medication with cell-based therapies.
“In the present day’s method to stem cell differentiation is artisanal, sluggish and inefficient. The trade measures the beginning and finish states of tissues throughout experiments, flying blind as to the actual time dynamics of cell biology, which leads to suboptimal tissue manufacturing protocols at greatest. With tons of of scientific trials ongoing and upcoming, we want a greater manner”, – is said on the corporate’s web site.
Elisa Pedone (Senior Analysis Scientist – Stem Cell Operations Lead at CellVoyant) is becoming a member of AUTOMA+ 2025 to introduce FateView – CellVoyant’s generalised platform for stem cell assays. CellVoyant makes use of pc imaginative and prescient to picture reside cells in tradition – this permits researchers to uncover and information optimum cell destiny, supporting real-time, data-driven selections in drug improvement. Their AI-first reside cell imaging expertise predicts and optimises stem cell differentiation, enabling superior cell analytics, course of improvement and controllable manufacturing of any cell or tissue within the physique.
Good provide chains: Transformation of pharma logistics
Logistics in pharma is present process a shift: the push for local weather neutrality, rising requires transparency and ongoing labour shortages are difficult conventional programs. To deal with these points, Fraunhofer Austria Analysis GmbH has launched its “Shared Logistics Place Paper”.
Fraunhofer Austria Analysis GmbH was based in 2008 and has turn out to be a well-established analysis accomplice for the Austrian trade. The corporate is at present engaged on application-oriented options for the good thing about the financial system and society. Analysis for follow is the central activity of Fraunhofer institutes and associates.
The “Shared Logistics Place Paper” outlines six key motion areas. On the coronary heart of the technique is the collaborative, cross-company use of each bodily belongings and information to make sure sustainable, resilient and future-ready provide chains.
“Our imaginative and prescient is that AI-supported, shared use of knowledge will steer the logistics provide chains of the longer term. By way of shut cooperation with firms and analysis companions, we wish to make this imaginative and prescient accessible to Austria’s logistics and transport trade,” – remark researchers at Fraunhofer Austria Analysis GmbH.
Martin Riester (Director Centre for Sustainable Manufacturing and Logistics at Fraunhofer Austria Analysis GmbH) is becoming a member of the dialogue on sensible provide chains at AUTOMA+ 2025 to share the outcomes of the corporate’s work.
In his discuss, Martin Riesteris going to current real-life examples of how Synthetic Intelligence and Information Science strategies are getting used to reinforce efficiency throughout varied levels of provide chains, pharma and others. The speaker goes to discover sensible purposes which have already been applied, together with upkeep and stock optimisation in addition to clever distribution methods. He’s additionally going to focus on transferable approaches and showcase how data-driven improvements can create extra resilient, environment friendly and responsive provide chains.
Digitalising EBR administration – quick and compliant
How a lot time do pharma firms have to adapt to shifting buyer calls for or new manufacturing batches? These processes may take months, and EBR/MES programs typically turn out to be the bottleneck, limiting the power to regulate workflows quick whereas staying compliant.
To deal with this, anic GmbH, a trailblazer in undertaking administration and software program options, has created anicomply – an internet utility with which Digital Batch Document (EBR) recipes may be revealed inside minutes in a totally digital course of.
“Even current SOPs or directions may be made digitally out there after inserting just a few markers and importing them to anicomply – inside minutes. This gives unprecedented flexibility for Digital Batch Document programs in validated environments”, – is said on the corporate’s web site.
anicomply permits customers to create recipes from predefined “blocks”, whereas captured manufacturing information is robotically transformed into digital experiences and batch data. Reside information switch to historians or information lakes allows real-time manufacturing monitoring and high quality optimisation.
One other key function is the mixing of digital signatures (ER), which permit paperwork and processes to be signed digitally – saving time and decreasing paper use. By making use of the four-eyes precept, anicomply ensures that each crucial determination is reviewed and authorized by no less than two authorised folks, reinforcing course of integrity and minimising the danger of errors.
Denis Nicklas (Founder & Managing Director at anic GmbH) is becoming a member of AUTOMA+ 2025 to inform extra about anic’s initiatives and share how they’re contributing to the pharmaceutical trade’s transformation and serving to to deal with limitations with digital and approaches.
Wanting forward: AI-driven future for pharma
Digitalisation has turn out to be a driver of lasting change that firms can not afford to disregard. What makes this second distinctive is the way in which numerous options – from AI in analysis to smarter logistics and digital compliance – are starting to attach, making a extra built-in and future-ready ecosystem.
AUTOMA+ 2025 goes to be the place to see these concepts come collectively, not solely by shows but additionally in conversations between consultants, innovators and decision-makers. It’s a chance to look past particular person instruments and discover how collaboration and digital pondering can form the following chapter of pharmaceutical improvement.
Touch upon this text through X: @IoTNow_ and go to our homepage IoT Now
